Eli Lilly Corp. buy SVB Leerink LLC
Start price
18.12.25
/
50%
€907.10
Target price
18.12.26
-
Performance (%)
15.93%
Price
17:20
€1,051.6
Summary
This prediction is currently active. The prediction currently has a performance of 15.93%. This prediction currently runs until 18.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 2.932% | 2.932% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for LLY provided by MarketBeat